Recruiting NA Lumbar Puncture

New treatment option for Lumbar Puncture

Official title Hemorrhage Elimination During Lumbar Puncture Using Ultrasound Measurements (HELPUS)

ClinicalTrials.gov ID: NCT07612644

What this study is testing

What it's testing
This is a clinical trial to determine the extent to which ultrasound-assisted lumbar puncture using a standardized procedure, including use of ultrasound to ascertain the presence of cerebrospinal fluid (CSF) at L3 - L5 and the optimal needle insertion distance, increases the acquisition rate of CSF that is interpretable for patient management.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 1 to 12

You may be able to join if

  • \- Neonates and infants (\< 12 months)
  • Hemodynamically stable
  • Undergoing a lumbar puncture for diagnostic testing

You likely can't join if

  • \- Infants \> 12 months and 1 day
  • Signs of clinical instability
  • Known spinal anomalies (e.g., spina bifida, meningomyelocele) or previous spinal surgery

The study team makes the final eligibility decision.

Where it's taking place

  • Nashville, Tennessee, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 1 day to 12 months. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Nashville, Tennessee, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.